(BG) Bunge - Ratings and Ratios
Oilseeds, Grains, Vegetable Oils, Flours, Sugar
Dividends
| Dividend Yield | 3.72% |
| Yield on Cost 5y | 6.55% |
| Yield CAGR 5y | 7.82% |
| Payout Consistency | 99.8% |
| Payout Ratio | 37.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.8% |
| Value at Risk 5%th | 41.4% |
| Relative Tail Risk | -6.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | 1.04 |
| CAGR/Max DD | 0.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.434 |
| Beta | 0.424 |
| Beta Downside | 0.403 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.82% |
| Mean DD | 15.49% |
| Median DD | 13.03% |
Description: BG Bunge October 30, 2025
Bunge Limited (NYSE: BG) is a global agribusiness and food company operating through four core segments: Agribusiness, Refined & Specialty Oils, Milling, and Sugar & Bioenergy. The Agribusiness unit trades and processes oilseeds (soy, rapeseed, canola, sunflower) and grains (wheat, corn), supplying animal feed, edible oil processors, and biofuel producers. The Refined & Specialty Oils segment manufactures packaged and bulk cooking oils, margarines, renewable-diesel feedstocks, and specialty ingredients such as lecithin. The Milling segment produces wheat flours, corn-based products, whole-grain ingredients, and non-GMO blends. The Sugar & Bioenergy segment generates sugar, ethanol, and electricity from sugarcane bagasse. Founded in 1818, Bunge is headquartered in Chesterfield, Missouri.
Key recent metrics: FY 2023 revenue of $62 billion, with the Agribusiness segment contributing roughly 55 % of total sales; EBITDA margin hovering around 9 % despite volatile soybean prices; and a 2024 guidance indicating a 5-7 % increase in soy-bean procurement volumes driven by strong demand from China’s feed and biodiesel markets. The company’s exposure to commodity price cycles and global grain supply-demand fundamentals makes it a bellwether for agricultural commodity trends, while its expanding renewable-diesel feedstock business aligns with the broader shift toward low-carbon fuels.
For deeper quantitative analysis, you might explore ValueRay’s detailed model on Bunge (BG).
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (1.32b TTM) > 0 and > 6% of Revenue (6% = 3.61b TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -4.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 17.67% (prev 15.10%; Δ 2.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 550.0m <= Net Income 1.32b (YES >=105%, WARN >=100%) |
| Net Debt (16.45b) to EBITDA (2.89b) ratio: 5.70 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (136.0m) change vs 12m ago -4.32% (target <= -2.0% for YES) |
| Gross Margin 5.79% (prev 6.54%; Δ -0.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 168.0% (prev 215.7%; Δ -47.72pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.36 (EBITDA TTM 2.89b / Interest Expense TTM 525.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.11
| (A) 0.23 = (Total Current Assets 26.72b - Total Current Liabilities 16.10b) / Total Assets 46.30b |
| (B) 0.28 = Retained Earnings (Balance) 13.05b / Total Assets 46.30b |
| (C) 0.06 = EBIT TTM 2.29b / Avg Total Assets 35.78b |
| (D) 0.24 = Book Value of Equity 6.95b / Total Liabilities 29.01b |
| Total Rating: 3.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.90
| 1. Piotroski 2.50pt |
| 2. FCF Yield 0.19% |
| 3. FCF Margin 0.10% |
| 4. Debt/Equity 1.13 |
| 5. Debt/Ebitda 5.70 |
| 6. ROIC - WACC (= 2.68)% |
| 7. RoE 11.23% |
| 8. Rev. Trend -36.50% |
| 9. EPS Trend -73.33% |
What is the price of BG shares?
Over the past week, the price has changed by -2.54%, over one month by -1.31%, over three months by +11.84% and over the past year by +12.42%.
Is BG a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 103.8 | 10.8% |
| Analysts Target Price | 103.8 | 10.8% |
| ValueRay Target Price | 99.5 | 6.2% |
BG Fundamental Data Overview November 26, 2025
P/E Trailing = 10.5304
P/E Forward = 10.917
P/S = 0.3112
P/B = 1.1598
P/EG = 1.7053
Beta = 0.78
Revenue TTM = 60.11b USD
EBIT TTM = 2.29b USD
EBITDA TTM = 2.89b USD
Long Term Debt = 9.81b USD (from longTermDebt, last quarter)
Short Term Debt = 6.82b USD (from shortTermDebt, last quarter)
Debt = 17.78b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.45b USD (from netDebt column, last quarter)
Enterprise Value = 32.77b USD (18.71b + Debt 17.78b - CCE 3.72b)
Interest Coverage Ratio = 4.36 (Ebit TTM 2.29b / Interest Expense TTM 525.0m)
FCF Yield = 0.19% (FCF TTM 61.0m / Enterprise Value 32.77b)
FCF Margin = 0.10% (FCF TTM 61.0m / Revenue TTM 60.11b)
Net Margin = 2.20% (Net Income TTM 1.32b / Revenue TTM 60.11b)
Gross Margin = 5.79% ((Revenue TTM 60.11b - Cost of Revenue TTM 56.63b) / Revenue TTM)
Gross Margin QoQ = 4.80% (prev 5.78%)
Tobins Q-Ratio = 0.71 (Enterprise Value 32.77b / Total Assets 46.30b)
Interest Expense / Debt = 1.14% (Interest Expense 202.0m / Debt 17.78b)
Taxrate = 33.73% (86.0m / 255.0m)
NOPAT = 1.52b (EBIT 2.29b * (1 - 33.73%))
Current Ratio = 1.66 (Total Current Assets 26.72b / Total Current Liabilities 16.10b)
Debt / Equity = 1.13 (Debt 17.78b / totalStockholderEquity, last quarter 15.77b)
Debt / EBITDA = 5.70 (Net Debt 16.45b / EBITDA 2.89b)
Debt / FCF = 269.7 (Net Debt 16.45b / FCF TTM 61.0m)
Total Stockholder Equity = 11.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.86% (Net Income 1.32b / Total Assets 46.30b)
RoE = 11.23% (Net Income TTM 1.32b / Total Stockholder Equity 11.79b)
RoCE = 10.60% (EBIT 2.29b / Capital Employed (Equity 11.79b + L.T.Debt 9.81b))
RoIC = 6.93% (NOPAT 1.52b / Invested Capital 21.88b)
WACC = 4.25% (E(18.71b)/V(36.49b) * Re(7.58%) + D(17.78b)/V(36.49b) * Rd(1.14%) * (1-Tc(0.34)))
Discount Rate = 7.58% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -3.81%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈473.0m ; Y1≈310.5m ; Y5≈142.0m
Fair Price DCF = 14.44 (DCF Value 2.79b / Shares Outstanding 193.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -73.33 | EPS CAGR: -10.84% | SUE: 3.27 | # QB: 1
Revenue Correlation: -36.50 | Revenue CAGR: 7.86% | SUE: -1.58 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.85 | Chg30d=+0.150 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=8.79 | Chg30d=+1.048 | Revisions Net=+1 | Growth EPS=+19.9% | Growth Revenue=+36.0%
Additional Sources for BG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle